Improving the management and outcome in haemolytic disease of the foetus and newborn

Blood Transfusion

Volumn 11, Issue 4, 2013, Pages 484-486

  Lopriore, Enrico ^a   Rath, Mirjam E A ^a   Liley, Helen ^b   Smits Wintjens, Vivianne E H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Mater Mother's Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN; MATERNAL ANTIBODY;

ALLOIMMUNIZATION; BRAIN DAMAGE; EDITORIAL; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FETUS DISEASE; HEMOLYTIC ANEMIA; HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN; HUMAN; HYPERBILIRUBINEMIA; INTRAUTERINE BLOOD TRANSFUSION; INTRAUTERINE INTRAVASCULAR RED CELL TRANSFUSION; KERNICTERUS; NEWBORN ANEMIA; NEWBORN DISEASE; NEWBORN MORBIDITY; PERINATAL MORTALITY; PHOTOTHERAPY; POSTNATAL CARE; PRENATAL CARE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL;

BLOOD TRANSFUSION, INTRAUTERINE; DATABASES, FACTUAL; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; MALE; PREGNANCY;

EID: 84891928722     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0147-13     Document Type: Editorial

References (30)

1. Stockman JA III. Overview of the state of the art of Rh disease: history, current clinical management, and recent progress. J Pediatr Hematol Oncol 2001; 23: 385-93.
2. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003; 43: 1661-6.
3. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008; 112: 164-76.
4. Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med 2008; 13: 265-71.
5. Koelewijn JM. Detection and prevention of pregnancy immunisation: The OPZI study. Faculty of Medicine, University of Amsterdam, The Netherlands 2009.
6. Birchenall KA, Illanes SE, Lopez F, et al. Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation. Blood Transfus 2013; 11: 548-52.
7. Lindenburg IT, Wolterbeek R, Oepkes D, et al. Quality control for intravascular intrauterine transfusion using cumulative sum (CUSUM) analysis for the monitoring of individual performance. Fetal Diagn Ther 2011; 29: 307-14.
8. Nicolini U, Kochenour NK, Greco P, et al. When to perform the next intra-uterine transfusion in patients with Rh alloimmunization: combined intravascular and intraperitoneal transfusion allows longer intervals. Fetal Ther 1989; 4: 14-20.
9. Santolaya J, Warsof SL. Combined intravascular-intraperitoneal transfusions in hydropic twins due to Rh (D) alloimmunization. Fetal Diagn Ther 1990; 5: 70-5.
10. Moise KJ Jr, Carpenter RJ Jr, Kirshon B, et al. Comparison of four types of intrauterine transfusion: effect on fetal hematocrit. Fetal Ther 1989; 4: 126-37.
11. Fisk NM, Gitau R, Teixeira JM, et al. Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling. Anesthesiology 2001; 95: 828-35.
12. Dodd JM, Windrim RC, Van Kamp IL. Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes. Cochrane Database Syst Rev 2012; 9: CD007096.
13. Smits-Wintjens VE, Rath ME, van Zwet EW, et al. Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease. Neonatology 2013; 103: 141-7.
14. De Boer I, Zeestraten EC, Lopriore E, et al. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008; 198: 54.
15. Smits-Wintjens VE, Walther FJ, Rath ME, et al. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 2011; 127: 680-6.
16. American Acadamy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
17. Rath ME, Smits-Wintjens VE, Lindenburg I, et al. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions. Vox Sang 2010; 99: 65-70.
18. Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992; 121: 93-7.
19. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-10.
20. Alpay F, Sarici SU, Okutan V, et al. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999; 88: 216-9.
21. Dagoglu T, Ovali F, Samanci N, Bengisu E. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995; 23: 264-71.
22. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002; 3: CD003313.
23. Santos MC, Sa CA, Gomes SC Jr, et al. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial. Transfusion 2013; 53: 777-82.
24. Walsh S, Molloy EJ. Towards evidence based medicine for paediatricians. Is intravenous immunoglobulin superior to exchange transfusion in the management of hyperbilirubinaemia in term neonates? Arch Dis Child 2009; 94: 739-41.
25. Kumar A, Teuber SS, Gershwin ME. Intravenous immunoglobulin: striving for appropriate use. Int Arch Allergy Immunol 2006; 140: 185-98.
26. Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M, et al. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 2010; 125: 139-44.
27. Nasseri F, Mamouri GA, Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J 2006; 27: 1827-30.
28. Elalfy MS, Elbarbary NS, Abaza HW. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn - a prospective randomized controlled trial. Eur J Pediatr 2011; 170: 461-7.
29. New HV, Stanworth SJ, Engelfriet CP, et al. Neonatal transfusions. Vox Sang 2009; 96: 62-85.
30. Rath ME, Smits-Wintjens VE, Walther FJ, Lopriore E. Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Early Hum Dev 2011; 87: 583-8.